Thromb Haemost 1979; 42(02): 641-648
DOI: 10.1055/s-0038-1666903
Original Article
Schattauer GmbH Stuttgart

Potentiating Effect of Adrenaline on Adenosine Diphosphate - Induced Reduction in Rabbit Circulating Platelet Count: Inhibition by Dihydroergotoxine

Ian B Holmes
The Biological and Medical Research Division, Sandoz Ltd., Basle, Switzerland
› Author Affiliations
Further Information

Publication History

Received 27 May 1978

Accepted 02 September 1978

Publication Date:
23 August 2018 (online)

Summary

The number of circulating platelets was monitored in anaesthetized rabbits by a contiuous flow technique, using a Technicon Autocounter®. Transient reductions in circulating platelet count induced by a submaximal dose of adenosine diphosphate (ADP) were potentiated by concomitant infusion of adrenaline at doses (1-25 μg/kg i.v.) which did not influence platelet count when infused alone. The adrenaline effect was dose-dependent. Repeated infusions of adrenaline at 15 min intervals resulted in reproducible reductions in circulating platelet count during an observation period of at least 105 min.

Dihydroergotoxine (DHET), administered either i.v. (2.5 - 10 μg/kg) or intraduodenally (i.d.; 25 - 100 μg/kg), inhibited adrenaline-induced potentiation dose-dependently; ADP- induced effects were not influenced. Duration of action was relatively long, and significant inhibitory activity was still apparent 50 (i.v.) and 115 (i.d.) min after drug administration.

DHET doses inhibiting adrenaline-induced potentiation of platelet aggregation in the rabbit are similar to doses used in the treatment of impaired human cerebral function. It is conceivable that DHET could prevent activitation of human platelets by catecholamines released into the blood stream in clinical stress situations.

 
  • References

  • 1 Ardlie NG, Glew G, Schwartz CJ. 1966; Influence of catecholamines on nucleotide- induced platelet aggregation. Nature, London 212: 415
  • 2 Barthel W, Markwardt F. 1974; Aggregation of blood platelets by biogenic amines and its inhibition by antiadrenergic and antiserotoninergic agents. Biochemical Pharmacology 23: 37
  • 3 Born GV R, Mills DC B, Roberts GC K. 1967; Potentiation of platelet aggregation by adrenaline. Journal of Physiology 191: 43 P
  • 4 Bygdeman S, Johnsen O. 1971; Studies on the effects of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine. Acta physiologica scandinavica 75: 129
  • 5 Doni M, Aragno R. 1977; Effect of catecholamines on ADP aggregation of rat platelets in vivo. Experientia 33: 1331
  • 6 Haft JI, Kranz PD, Albert FJ, Fani K. 1972; Intravascular platelet aggregation in the heart induced by norepinephrine. Circulation 46: 698
  • 7 Holmes IB, Smith GM, Freuler F. 1977; The effect of intravenous adenosine diphosphate on the number of circulating platelets in experimental animals: inhibition by prostaglandin E1, dipyridamole, SH-869 and VK-774. Thrombosis and Haemostasis 37: 36
  • 8 Holzbauer M, Vogt M. 1954; The concentration of adrenaline in the peripheral blood during insulin hypoglycaemia. British Journal of Pharmacology 9: 249
  • 9 Markwardt F, GLUSA E, Barthel W. 1977; Influence of dihydroergotoxine on platelet aggregation in rabbits. Thrombosis Research 10: 783
  • 10 Mills DC B. 1970; Platelet aggregation and platelet nucleotide concentration in different species. Symposia of the Zoological Society of London 27: 99
  • 11 Mills DC B, Roberts GC K. 1967; Effects of adrenaline on human blood platelets. Journal of Physiology 193: 443
  • 12 Moriau M, Noel H, Masure R. 1974; Effects of alpha and beta receptor stimulating and blocking agents on experimental disseminated intravascular coagulation. Thrombosis et Diathesis Haemorrhagica 32: 157
  • 13 Müller-Schweinttzer E, Weidmann H. Basic pharmacological properties. In Ergot Alkaloids and Related Compounds. Handbook of Experimental Pharmacology. Berde B, Schild HO. (eds.) Vol. 49, pp 87-232 Springer-Verlag; Berlin: 1978. in press
  • 14 Mustard JF, Packham MA. 1970; Factors influencing platelet function: adhesion, release and aggregation. Pharmacological Reviews 22: 97
  • 15 Smith GM, Freuler F. 1973; The measurement of intravascular aggregation by continuous platelet counting. Bibliotheca anatomica 12: 229
  • 16 Tothill A. 1967; Investigation of adrenaline reversal in the rat uterus by induction of resistance to isopr�naline. British Journal of Pharmacology 29: 291